“Our proprietary technology enables us to routinely and homogenously load hundreds to thousands of copies of drugs per exosome, which is one to two orders of magnitude more than what has been de ...
Under terms of the agreement, Lilly will gain access to Exosome's technology with the aim of identifying key gene mutations and expression levels in blood that may be correlated with drug response ...
EVs are known to play a key role in aging, inflammation, disease progression and inter-cellular communication. EVs or exosomes technology will become a landmark in biological preparation development ...
US biotech PureTech Health has signed a potential billion-dollar deal with Roche based around its exosome technology that allows for oral administration of complex payloads – in this case ...
EVs or exosomes technology will become a landmark in biological preparation development and human health. Professor Randy Schekman provided an in-depth view of the key bridging role of exosomes in ...
While exosome technology is still in its early stages clinically, it is emerging as a novel drug delivery system that is beginning to enter clinical applications. Currently, EVs are being studied ...